20 results
8-K
EX-99.1
IKNA
Ikena Oncology Inc
15 Apr 21
Ikena Oncology Appoints Dr. Maria Koehler to its Board of Directors
7:43am
(NASDAQ: BCYC) where she was Chief Medical Officer. Prior to Bicycle, she was Vice President of Strategy, Innovation and Collaborations for the Oncology
8-K
EX-99.1
IKNA
Ikena Oncology Inc
21 Feb 24
Ikena Oncology Appoints Caroline Germa, M.D. as Chief Medical Officer
4:29pm
innovation in the targeted oncology space.
“Our clinical team is firing on all cylinders to bring the right patients into our ongoing IK-930 and IK
DEF 14A
IKNA
Ikena Oncology Inc
27 Apr 22
Definitive proxy
4:32pm
2017, most recently as Vice President of Oncology Strategy, Innovation and Collaborations. Prior to joining Pfizer, Dr. Koehler was the group leader … : SPRO). Dr. Formela is a member of the Partners Healthcare Innovation Growth Board and a former trustee of the Boston Institute of Contemporary Art. Dr
S-1/A
IKNA
Ikena Oncology Inc
22 Mar 21
IPO registration (amended)
8:51am
and enforceable patents or trade secrets that cover these activities. We also rely on trade secrets, know-how and continuing technological innovation to develop … called the Biologics Price Competition and Innovation Act of 2009, or BPCIA, which created an abbreviated approval pathway for biologic products
10-K
cqbc4j
17 Mar 22
Annual report
6:31am
DRS
drh6t47l0 bi
8 Jan 21
Draft registration statement
12:00am
S-1
ozvcgt9h qu3uc3a
5 Mar 21
IPO registration
2:59pm
DRS/A
xr8z81xz 327x
11 Feb 21
Draft registration statement (amended)
12:00am
424B4
hm3liug0
26 Mar 21
Prospectus supplement with pricing info
5:04pm
10-Q
0o6vm32z 8l5
13 May 21
Quarterly report
4:15pm
- Prev
- 1
- Next